Search Results
Jan 19, 2026, 02:00 ET AI Won't Lift Human Productivity Without Learning, New Pearson Research Finds
Pairing AI with skilling could add up to $6.6T to the U.S. economy by 2034 and deliver the return on investment businesses wantDAVOS, Switzerland, Jan. 19, 2026 /PRNewswire/ -- New research from
More news about: Pearson
Jan 19, 2026, 02:00 ET AI Won't Lift Human Productivity Without Learning, New Pearson Research Finds
Pairing AI with skilling could add up to $6.6T to the U.S. economy by 2034 and deliver the return on investment businesses wantDAVOS, Switzerland, Jan. 19, 2026 /PRNewswire/ -- New research from
More news about: Pearson
Jan 18, 2026, 19:55 ET JAPAN SUI COLLECTION in Kyoto: Die Essenz japanischer Schönheit und Tradition in die Welt tragen - Bericht über die Veranstaltung im Gästehaus der Präfektur Kyoto
https://drive.google.com/drive/folders/1U8DtHJUEhBzO_T_GAmso_1ijcd2Ws9nQ?usp=sharing
More news about: Cabinet Office, Government of Japan
Jan 18, 2026, 19:30 ET AbelZeta Announces Remaining China Rights to GPC3 Armored CAR-T Therapy to be Acquired by AstraZeneca
reach" said Tony (Bizuo) Liu, Chairman and CEO of AbelZeta.C-CAR031 is an autologous, Glypican 3 (GPC3)-targeting chimeric antigen receptor T-Cell (CAR-T) therapy, designed using AstraZeneca's dominant negative transforming growth factor-beta receptor II armoring platform, and is currently being investigated
More news about: AbelZeta Pharma, Inc.
Jan 18, 2026, 18:30 ET Elliott Opposes Toyota Fudosan's Revised Tender Offer for Toyota Industries Corporation
L.P.Investor Contacts:Okapi Partners LLCNew York: Pat McHughT:+1 212 297 0720Toll Free: (877) 629-6357London: Christian JacquesT: +44 20 3031 [email protected]
More news about: Elliott Investment Management L.P.
Jan 18, 2026, 10:15 ET /C O R R E C T I O N -- Future of Equestrian Sport Alliance (FESA)/
More news about: Future of Equestrian Sport Alliance (FESA)
Jan 17, 2026, 20:11 ET /C O R R E C T I O N -- Future of Equestrian Sport Alliance (FESA)/
More news about: Future of Equestrian Sport Alliance (FESA)
Jan 16, 2026, 20:01 ET /C O R R E C T I O N -- Reflex Sales Group/
More news about: Reflex Sales Group
Jan 16, 2026, 17:37 ET Stellus Capital Investment Corporation Announces $0.34 First Quarter 2026 Regular Dividend, Payable Monthly in Increments of $0.1133 in February, March, and April 2026
the first quarter of 2026. The regular dividend of $0.34 per share will be paid to shareholders of record in February, March, and April 2026. Robert T. Ladd, Chief Executive Officer of the Company, stated, "The reduction in our regular dividend in the first quarter reflects the lower interest rate environment."
More news about: Stellus Capital Investment Corporation
Jan 16, 2026, 13:43 ET AbbVie Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Genmab's DuoBody-CD3 technology is designed to direct cytotoxic T cells selectively to elicit an immune response toward target cell types. Epcoritamab is designed to simultaneously bind to CD3 on T cells and CD20 on B cells and induces T-cell-mediated killing of CD20+ cells.7Epcoritamab
More news about: AbbVie
Jan 16, 2026, 12:24 ET /C O R R E C T I O N -- Alkami Technology, Inc./
More news about: Alkami Technology, Inc.
Jan 16, 2026, 11:00 ET BDT & MSD APPOINTS ADAM BESHARA AS PRESIDENT
www.bdtmsd.com.Media ContactsBDT & MSD PartnersSara Evans / Matthew GlasserT: (312) 529-6548 / (312) 385-2883E: [email protected]
More news about: BDT & MSD Partners
Jan 16, 2026, 10:50 ET /C O R R E C T I O N -- New York Stock Exchange/
More news about: New York Stock Exchange
Jan 16, 2026, 09:27 ET CPNG INVESTOR ALERT: Hagens Berman Investigating Claims in Pending Coupang, Inc. (CPNG) Suit Over Data Breach
youtu.be/jBOcNVx13T8CPNG Case at a Glance
More news about: Hagens Berman Sobol Shapiro LLP
Jan 16, 2026, 09:20 ET Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform
Wash., Jan. 16, 2026 /PRNewswire/ -- Vaximm AG, a subsidiary of OSR Holdings, Inc. and a pioneer in oral T-cell immunotherapies for cancer, today announced the appointment of Sébastien Wieckowski, PhD, as Chief Scientific Officer (CSO). This appointment strategically
More news about: OSR Holdings
Jan 16, 2026, 08:45 ET Volition Sponsors Symposium at Veterinary Meeting and Expo
otherwise specified, all references to "$" refer to the legal currency of the United States of America.1. Wilson-Robles, H.M., Bygott, T., Kelly, T.K. et al. Evaluation of plasma nucleosome concentrations in dogs with a variety of common cancers and in healthy dogs. BMC Vet Res 18, 329 (2022).
More news about: VolitionRx Limited
Jan 16, 2026, 08:33 ET TELUS completes redemption of 3.75% Notes, Series CV due March 10, 2026
required by law, TELUS disclaims any intention or obligation to update or revise forward-looking statements.About TELUSTELUS (TSX: T, NYSE: TU) is a world-leading communications technology company operating in more than 45 countries and generating over $20 billion in annual revenue
More news about: TELUS Corporation
Jan 16, 2026, 08:33 ET TELUS completes redemption of 3.75% Notes, Series CV due March 10, 2026
required by law, TELUS disclaims any intention or obligation to update or revise forward-looking statements.About TELUSTELUS (TSX: T, NYSE: TU) is a world-leading communications technology company operating in more than 45 countries and generating over $20 billion in annual revenue
More news about: TELUS Corporation
Jan 16, 2026, 08:32 ET Republic of Trinidad and Tobago Announces Cash Tender Offer
https://www.gbsc-usa.com/t_t/ DISCLAIMERThe Tender Offer Document is not for release, publication or distribution to any person located or
More news about: The Republic of Trinidad and Tobago
Jan 16, 2026, 08:00 ET Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape
antibody selectively eliminating CCR8+ T regulatory cells while sparing other T cells."This publication presents the robust pharmacology of tagmokitug in preclinical and clinical studies, and with a selectivity profile and potent binding and killing of CCR8+ T regulatory cells and not other immune
More news about: Equity Insider
Jan 16, 2026, 08:00 ET Henlius Showcases "Globalisation 2.0" Strategy and Mid-to-Long-Term Innovation Blueprint at JPM 2026
featuring longer persistence of activated T cells and greater efficacy in solid tumour treatment.HLX3902: Potential FIC STEAP1 × CD3 × CD28 trispecific TCE developed on the proprietary TCE platform, demonstrating superior antitumour activity, and increased T-cell infiltration and persistence
More news about: Henlius
Jan 16, 2026, 08:00 ET New clinical data highlights CAPLYTA® (lumateperone) as a promising option for achieving remission in adults with major depressive disorder
Nov;163(11):1905-17. doi:10.1176/ajp.2006.163.CAPLYTA® [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc.Su YA and Si T. Progress and challenges in research of the mechanisms of anhedonia in major depressive disorder. Gen Psychiatr. 2022;35:e100724. doi:10.1136/gpsych-2021-100724 Pandya
More news about: Johnson & Johnson
Jan 16, 2026, 05:30 ET M&T Bank Corporation (NYSE:MTB) announces fourth quarter and full-year 2025 results
https://ir.mtb.com/news-events/events-presentations. About M&TM&T is a financial holding company headquartered in Buffalo, New York. M&T's principal banking subsidiary, M&T Bank, provides banking products and services with a branch and ATM network spanning
More news about: M&T Bank Corporation
Jan 16, 2026, 05:30 ET ORVANA REPORTS Q1 FY2026 PRODUCTION AND EXPLORATION RESULTS; AND PROVIDES UPDATE ON OXIDES STOCKPILE PROJECT AT DON MARIO, BOLIVIA
exceeding 16.7 g/t Au are automatically repeated by the metallic screening method, to confirm the grade of the sample. For A208 orebody core samples is used a 1000 g sub-sample of each split and 250 g sub-samples are split. 50 g samples are twice analyzed. In case of the twice analysis don´t match, a metaling
More news about: Orvana Minerals Corp.